Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-08 Sale | 2026-09-10 4:23 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President, COO & Interim CEO | 17,500 | $22.9 | $400,716 | 215,893 (Direct) | View |
| 2026-08-10 Sale | 2026-08-12 4:19 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 12,500 | $27.97 | $349,591 | 156,191 (Direct) | View |
| 2026-08-10 Sale | 2026-08-12 4:19 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 10,000 | $27.98 | $279,750 | 472,698 (Direct) | View |
| 2026-08-10 Sale | 2026-08-12 4:19 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 18,750 | $27.98 | $524,533 | 233,393 (Direct) | View |
| 2026-07-10 Sale | 2026-07-14 4:22 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 10,000 | $28.42 | $284,198 | 482,698 (Direct) | View |
| 2026-07-08 Sale | 2026-07-10 4:10 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 28,750 | $28.98 | $833,129 | 252,143 (Direct) | View |
| 2026-07-08 Sale | 2026-07-10 4:10 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 28,000 | $28.85 | $807,672 | 227,683 (Direct) | View |
| 2026-05-21 Sale | 2026-05-26 5:48 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $20.42 | $187,883 | 215,939 (Direct) | View |
| 2026-05-18 Sale | 2026-05-20 4:07 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 15,000 | $20.04 | $300,579 | 508,259 (Direct) | View |
| 2026-05-15 Sale | 2026-05-18 4:24 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 12,500 | $20.29 | $253,649 | 292,975 (Direct) | View |
| 2026-04-27 Sale | 2026-04-28 7:49 pm | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 5,500 | $22.88 | $125,830 | 97,199 (Direct) | View |
| 2026-04-21 Sale | 2026-04-22 4:53 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $23 | $211,614 | 185,099 (Direct) | View |
| 2026-04-20 Sale | 2026-04-20 7:27 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 15,000 | $23.61 | $354,146 | 1,268,921 (Direct) | View |
| 2026-04-15 Sale | 2026-04-17 4:55 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 12,500 | $23.01 | $287,591 | 305,475 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 7:21 pm | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 5,500 | $18.95 | $104,229 | 102,699 (Direct) | View |
| 2026-03-23 Sale | 2026-03-24 7:45 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $18.52 | $170,348 | 194,299 (Direct) | View |
| 2026-03-18 Sale | 2026-03-20 5:02 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 15,000 | $18.82 | $282,366 | 877,810 (Direct) | View |
| 2026-03-16 Sale | 2026-03-17 5:36 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 12,500 | $19.66 | $245,714 | 317,975 (Direct) | View |
| 2026-03-09 Sale | 2026-03-11 4:47 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 36,766 | $19.17 | $704,657 | 530,499 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 7:27 pm | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 8,234 | $18.74 | $154,325 | 1,032,431 (Direct) | View |
| 2026-03-03 Sale | 2026-03-05 7:10 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 17,392 | $18.16 | $315,893 | 330,475 (Direct) | View |
| 2026-03-03 Sale | 2026-03-05 7:08 pm | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 16,518 | $18.22 | $300,971 | 366,030 (Direct) | View |
| 2026-03-03 Sale | 2026-03-05 7:06 pm | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 16,500 | $18.52 | $305,610 | 177,412 (Direct) | View |
| 2026-02-26 Purchase | 2026-03-02 4:22 pm | Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 300,000 | $16 | $4,800,000 | 9,455,993 (Indirect) | View |
| 2026-02-25 Sale | 2026-02-27 4:13 pm | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 3,631 | $18.04 | $65,501 | 347,867 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-08 Exercise | 2026-09-10 4:23 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President, COO & Interim CEO | 17,500 | $3.7898 | 215,893 (Direct) | View |
| 2026-09-08 Exercise | 2026-09-10 4:23 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President, COO & Interim CEO | 17,500 | $0 | 215,893 (Direct) | View |
| 2026-08-12 Option Award | 2026-08-14 4:54 pm | N/A 2036-08-12 | Bicara Therapeutics Inc. | BCAX | Larson Jennifer Chief Financial Officer | 285,000 | $0 | 285,000 (Direct) | View |
| 2026-08-10 Exercise | 2026-08-12 4:19 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 12,500 | $3.7898 | 156,191 (Direct) | View |
| 2026-08-10 Exercise | 2026-08-12 4:19 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 12,500 | $0 | 156,191 (Direct) | View |
| 2026-08-10 Exercise | 2026-08-12 4:19 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 10,000 | $3.7898 | 472,698 (Direct) | View |
| 2026-08-10 Exercise | 2026-08-12 4:19 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 10,000 | $0 | 472,698 (Direct) | View |
| 2026-08-10 Exercise | 2026-08-12 4:19 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 18,750 | $3.7898 | 233,393 (Direct) | View |
| 2026-08-10 Exercise | 2026-08-12 4:19 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 18,750 | $0 | 233,393 (Direct) | View |
| 2026-07-28 Option Award | 2026-07-29 4:18 pm | N/A 2036-07-28 | Bicara Therapeutics Inc. | BCAX | Bender Jeremy Director | 38,950 | $0 | 38,950 (Direct) | View |
| 2026-07-28 Option Award | 2026-07-29 4:18 pm | N/A 2036-07-28 | Bicara Therapeutics Inc. | BCAX | Oliger Christy J. Director | 38,950 | $0 | 38,950 (Direct) | View |
| 2026-07-10 Exercise | 2026-07-14 4:22 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 10,000 | $3.7898 | 482,698 (Direct) | View |
| 2026-07-10 Exercise | 2026-07-14 4:22 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 10,000 | $0 | 482,698 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-10 4:10 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 18,750 | $3.7898 | 252,143 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-10 4:10 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 18,750 | $0 | 252,143 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-10 4:10 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 12,500 | $3.7898 | 227,683 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-10 4:10 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 12,500 | $0 | 227,683 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:43 pm | N/A 2036-06-09 | Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 19,475 | $0 | 19,475 (Indirect) | View |
| 2026-06-09 Option Award | 2026-06-10 4:35 pm | N/A 2036-06-09 | Bicara Therapeutics Inc. | BCAX | Bowden Christopher Director | 19,475 | $0 | 19,475 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:34 pm | N/A 2036-06-09 | Bicara Therapeutics Inc. | BCAX | Haviland Kate Director | 19,475 | $0 | 19,475 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:34 pm | N/A 2036-06-09 | Bicara Therapeutics Inc. | BCAX | Mazumdar-Shaw Kiran Director | 19,475 | $0 | 19,475 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:33 pm | N/A 2036-06-09 | Bicara Therapeutics Inc. | BCAX | Robertson Scott M. Director | 19,475 | $0 | 19,475 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:33 pm | N/A 2036-06-09 | Bicara Therapeutics Inc. | BCAX | POWELL MICHAEL Director | 19,475 | $0 | 19,475 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:32 pm | N/A 2036-06-09 | Bicara Therapeutics Inc. | BCAX | Simson Jake Director | 19,475 | $0 | 19,475 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-26 5:48 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $3.7898 | 215,939 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-26 5:48 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $0 | 215,939 (Direct) | View |
| 2026-05-18 Exercise | 2026-05-20 4:07 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 15,000 | $3.7898 | 508,259 (Direct) | View |
| 2026-05-18 Exercise | 2026-05-20 4:07 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 15,000 | $0 | 508,259 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-18 4:24 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 8,000 | $3.7898 | 292,975 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-18 4:24 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 8,000 | $0 | 292,975 (Direct) | View |
| 2026-05-08 Option Award | 2026-05-12 4:04 pm | N/A 2036-05-08 | Bicara Therapeutics Inc. | BCAX | Schelman William Chief Medical Officer | 85,000 | $0 | 85,000 (Direct) | View |
Ownership | 2026-05-12 4:02 pm | N/A 2035-10-01 | Bicara Therapeutics Inc. | BCAX | Schelman William Chief Medical Officer | 0 | $0 | 175,000 (Direct) | View |
| 2026-04-27 Exercise | 2026-04-28 7:49 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 5,500 | $3.7898 | 97,199 (Direct) | View |
| 2026-04-27 Exercise | 2026-04-28 7:49 pm | N/A 2023-08-08 | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 5,500 | $0 | 97,199 (Direct) | View |
| 2026-04-21 Exercise | 2026-04-22 4:53 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $3.7898 | 185,099 (Direct) | View |
| 2026-04-21 Exercise | 2026-04-22 4:53 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $0 | 185,099 (Direct) | View |
| 2026-04-16 Exercise | 2026-04-20 7:27 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 7,080 | $5.4537 | 1,268,921 (Direct) | View |
| 2026-04-16 Exercise | 2026-04-20 7:27 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 8,226 | $4.4369 | 1,268,921 (Direct) | View |
| 2026-04-16 Exercise | 2026-04-20 7:27 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 22,454 | $3.7898 | 1,268,921 (Direct) | View |
| 2026-04-16 Exercise | 2026-04-20 7:27 pm | N/A 2032-10-04 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 37,760 | $0 | 1,268,921 (Direct) | View |
| 2026-04-15 Exercise | 2026-04-17 4:55 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 8,000 | $3.7898 | 305,475 (Direct) | View |
| 2026-04-15 Exercise | 2026-04-17 4:55 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 8,000 | $0 | 305,475 (Direct) | View |
| 2026-03-25 Exercise | 2026-03-26 7:21 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 5,500 | $3.7898 | 102,699 (Direct) | View |
| 2026-03-25 Exercise | 2026-03-26 7:21 pm | N/A 2023-08-08 | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 5,500 | $0 | 102,699 (Direct) | View |
| 2026-03-23 Exercise | 2026-03-24 7:45 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $3.7898 | 194,299 (Direct) | View |
| 2026-03-23 Exercise | 2026-03-24 7:45 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 9,200 | $0 | 194,299 (Direct) | View |
| 2026-03-18 Exercise | 2026-03-20 5:02 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 15,000 | $3.7898 | 877,810 (Direct) | View |
| 2026-03-18 Exercise | 2026-03-20 5:02 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 15,000 | $0 | 877,810 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-17 5:36 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 8,000 | $3.7898 | 317,975 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-17 5:36 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 8,000 | $0 | 317,975 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 4:47 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 36,766 | $3.7898 | 530,499 (Direct) | View |
| 2026-03-09 Exercise | 2026-03-11 4:47 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 36,766 | $0 | 530,499 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 7:27 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 8,234 | $3.7898 | 1,032,431 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 7:27 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer | 8,234 | $0 | 1,032,431 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:10 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 12,892 | $3.7898 | 330,475 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:10 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 12,892 | $0 | 330,475 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:08 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 16,518 | $3.7898 | 366,030 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:08 pm | N/A 2033-04-05 | Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer | 16,518 | $0 | 366,030 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:06 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 16,500 | $3.7898 | 177,412 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 7:06 pm | N/A 2023-08-08 | Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer | 16,500 | $0 | 177,412 (Direct) | View |
| 2026-02-25 Exercise | 2026-02-27 4:13 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 3,108 | $3.7898 | 347,867 (Direct) | View |
| 2026-02-25 Exercise | 2026-02-27 4:13 pm | N/A 2033-08-08 | Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO | 3,108 | $0 | 347,867 (Direct) | View |